NCT00006368
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Carcinoma, Islet Cell
Explore clinical trials studying Carcinoma, Islet Cell. Study availability and eligibility vary by location and protocol.
26 public trials
1 recruiting study
Carcinoma, Islet Cell trial results
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00005842
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
- Locations
-
- Brooke Army Medical Center Fort Sam Houston, Texas, United States
- Institute for Drug Development San Antonio, Texas, United States
NCT00019786
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +38 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
NCT00005860
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +71 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Active, Not Recruiting
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
NCT01824875
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
- Locations
-
- Kaiser Anaheim Medical Center Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
- Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
- Kaiser Foundation Hospital Bellflower, California, United States